SCOPUS 정보 검색 플랫폼

Onkologie

Volumn 25, Issue 1, 2002, Pages 74-76

Is there a standard for the palliative treatment of melanoma?

(1) Schadendorf, Dirk a

a UNIVERSITY OF HEIDELBERG (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CARMUSTINE; CISPLATIN; DACARBAZINE; INTERLEUKIN 2; TAMOXIFEN; TEMOZOLOMIDE;

BONE MARROW DEPRESSION; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE COURSE; DRUG MEGADOSE; DRUG RESPONSE; FATIGUE; HUMAN; IMMUNOTHERAPY; MELANOMA; METASTASIS; NAUSEA; NOTE; PALLIATIVE THERAPY; RANDOMIZATION; REMISSION; RISK; TOXICITY; TREATMENT OUTCOME; VOMITING;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DACARBAZINE; EVIDENCE-BASED MEDICINE; HUMANS; INTERFERONS; INTERLEUKIN-2; MELANOMA; PALLIATIVE CARE; RANDOMIZED CONTROLLED TRIALS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0036119064 PISSN: 0378584X EISSN: None Source Type: Journal
DOI: 10.1159/000055210 Document Type: Note

Times cited : (24)

References (17)

1
- 0029621857
- Malignant melanoma
- (1995) Curr Ther Concepts , vol.18 , pp. 534-547
- Tilgen, W.¹

2
- 0035452330
- Drug-resistance in human melanoma
- (2001) Int J Cancer , vol.93 , pp. 617-622
- Helmbach, H.¹ Rossman, E.² Kern, M.A.³ Schadendorf, D.⁴

3
- 0031806982
- Chemoresistance of human malignant melanoma: Cellular and molecular aspects
- (1998) Onkologie , vol.21 , pp. 105-110
- Berger, W.¹ Elbing, L.² Mischke, M.³

4
- 0003272682
- Systemic treatments for metastatic cutaneous melanoma
- Cochrane Review. Oxford: Update Software
- (2001) The Cochrane Library , vol.4
- Crosby, T.¹ Fish, R.² Coles, B.³ Mason, M.D.⁴

5
- 0035136793
- Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: A meta-analysis of 3273 patients from 20 randomized trials
- (2001) Melanoma Res , vol.11 , pp. 75-81
- Huncharek, M.¹ Caubet, Jf.² Mcgarry, R.³

6
- 0032858487
- Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma
- (1999) J Clin Oncol , vol.17 , pp. 2745-2751
- Chapman, P.B.¹ Einhorn, L.H.² Meyers, M.L.³ Saxman, S.⁴ Destro, A.N.⁵ Panageas, K.S.⁶ Begg, C.B.⁷ Agarwala, S.S.⁸ Schuchter, L.M.⁹ Ernstoff, M.S.¹⁰ Houghton, A.N.¹¹ Kirkwood, J.M.¹²

7
- 0033989205
- Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma
- Erratum in J Clin Oncol 2000;18:2351. Comment in J Clin Oncol 2000;18:2185
- (2000) J Clin Oncol , vol.18 , pp. 158-166
- Middleton, Mr.¹ Grob, Jj.² Aaronson, N.³ Fierlbeck, G.⁴ Tilgen, W.⁵ Seiter, S.⁶ Gore, M.⁷ Aamdal, S.⁸ Cebon, J.⁹ Coates, A.¹⁰ Dreno, B.¹¹ Henz, M.¹² Schadendorf, D.¹³ Kapp, A.¹⁴ Weiss, J.¹⁵ Fraass, U.¹⁶ Statkevich, P.¹⁷ Muller, M.¹⁸ Thatcher, N.¹⁹

8
- 0026625695
- Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen
- Comments in: N Engl J Med 1992;327:560-561. Comments in New Engl J Med 1993;328:140-141
- (1992) N Engl J Med , vol.327 , pp. 516-523
- Cocconi, G.¹ Bella, M.² Calabresi, F.³ Tonato, M.⁴ Canaletti, R.⁵ Boni, C.⁶ Buzzi, F.⁷ Ceci, G.⁸ Corgna, E.⁹ Costa, P.¹⁰

9
- 8944261598
- Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma
- National Cancer Institute of Canada Clinical Trials Group
- (1996) J Clin Oncol , vol.14 , pp. 2083-2090
- Rusthoven, J.J.¹ Quirt, I.C.² Iscoe, N.A.³ Mcculloch, P.B.⁴ James, K.W.⁵ Lohmann, R.C.⁶ Jensen, J.⁷ Burdette-Radoux, S.⁸ Bodurtha, A.J.⁹ Silver, H.K.¹⁰ Verma, S.¹¹ Armitage, G.R.¹² Zee, B.¹³ Bennett, K.¹⁴

10
- 0031805725
- Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: An Eastern Cooperative Oncology Group study
- (1998) J Clin Oncol , vol.16 , pp. 1743-1751
- Falkson, C.I.¹ Ibrahim, J.² Kirkwood, J.M.³ Coates, A.S.⁴ Atkins, M.B.⁵ Blum, R.H.⁶

11
- 0025837770
- Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma
- (1991) J Clin Oncol , vol.9 , pp. 1403-1408
- Falkson, C.I.¹ Falkson, G.² Falkson, H.C.³

12
- 0344791670
- Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-alpha-2a in patients with metastatic melanoma: A Federation Nationale des Centres de Lutte Contre le Cancer Multicenter, Parallel Study
- (1999) Cancer , vol.85 , pp. 1060-1066
- Dorval, T.¹ Negrier, S.² Chevreau, C.³ Avril, M.F.⁴ Baume, D.⁵ Cupissol, D.⁶ Oskam, R.⁷ De Peuter, R.⁸ Vinke, J.⁹ Herrera, A.¹⁰ Escudier, B.¹¹

13
- 0342894822
- Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: A randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group
- (1997) J Clin Oncol , vol.15 , pp. 2579-2588
- Keilholz, U.¹ Goey, S.H.² Punt, C.J.³ Proebstle, T.M.⁴ Salzmann, R.⁵ Scheibenbogen, C.⁶ Schadendorf, D.⁷ Lienard, D.⁸ Enk, A.⁹ Dummer, R.¹⁰ Hantich, B.¹¹ Geueke, A.M.¹² Eggermont, A.M.¹³

14
- 0032976897
- Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b
- (1999) J Clin Oncol , vol.17 , pp. 968-975
- Rosenberg, S.A.¹ Yang, J.C.² Schwartzentruber, D.J.³ Hwu, P.⁴ Marincola, F.M.⁵ Topalian, S.L.⁶ Seipp, C.A.⁷ Einhorn, J.H.⁸ White, D.E.⁹ Steinberg, S.M.¹⁰

15
- 17744388962
- Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: A randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG)
- (2001) Brit J Cancer , vol.84 , pp. 1036-1042
- Hauschild, A.¹ Garbe, C.² Stolz, W.³ Ellwanger, U.⁴ Seiter, S.⁵ Dummer, R.⁶ Ugurel, S.⁷ Sebastian, G.⁸ Nashan, D.⁹ Linse, R.¹⁰ Achtelik, W.¹¹ Mohr, P.¹² Kaufmann, R.¹³ Fey, M.¹⁴ Ulrich, J.¹⁵ Tilgen, W.¹⁶

16
- 0036137546
- Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma
- (2002) J Clin Oncol , vol.20 , pp. 125-133
- Agarwala, S.S.¹ Glaspy, J.² O'Day, S.J.³ Mitchell, M.⁴ Gutheil, J.⁵ Whitman, E.⁶ Gonzalez, R.⁷ Hersh, E.⁸ Feun, L.⁹ Belt, R.¹⁰ Meyskens, F.¹¹ Hellstrand, K.¹² Wood, D.¹³ Kirkwood, J.M.¹⁴ Gehlsen, K.R.¹⁵ Naredi, P.¹⁶

17
- 0343240340
- Cell-based vaccination against melanoma-background, preliminary results, and perspective
- (1999) J Mol Med , vol.77 , pp. 593-608
- Sun, Y.¹ Paschen, A.² Schadendorf, D.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.